Cite
Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.
MLA
Özdemir, Zehra Narlı, et al. “Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.” Turkish Journal of Hematology, vol. 41, no. 1, Jan. 2024, pp. 26–36. EBSCOhost, https://doi.org/10.4274/tjh.galenos.2024.2023.0430.
APA
Özdemir, Z. N., İpek, Y., Patır, P., Ermiş, G., Çiftçiler, R., Özmen, D., Baysal, M., Gürsoy, V., Yıldızhan, E., Güven, S., Ercan, T., Elibol, T., Mersin, S., Genç, E., Davulcu, E. A., Karakuş, V., Erkut, N., Güneş, G., Küçükkaya, R. D., & Eşkazan, A. E. (2024). Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients. Turkish Journal of Hematology, 41(1), 26–36. https://doi.org/10.4274/tjh.galenos.2024.2023.0430
Chicago
Özdemir, Zehra Narlı, Yıldız İpek, Püsem Patır, Gözde Ermiş, Rafiye Çiftçiler, Deniz Özmen, Mehmet Baysal, et al. 2024. “Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients.” Turkish Journal of Hematology 41 (1): 26–36. doi:10.4274/tjh.galenos.2024.2023.0430.